Major depressive disorder (MDD) is a leading cause of distress, disability, and suicides. As
per the latest WHO report, MDD affects more than 260 million people worldwide. Despite …

Cognitive dysfunction in type 1 and type 2 diabetes share many similarities, but important
differences do exist. A primary distinguishing feature of type 2 diabetes is that people with …

Context Association between obesity and depression has repeatedly been established. For
treatment and prevention purposes, it is important to acquire more insight into their …

Metabolic syndrome (MetS), a clustering of risk factors for type 2 diabetes mellitus and
cardiovascular disease, has been associated with cognitive dysfunction and brain …

Inflammation and altered glutamate metabolism are two pathways implicated in the
pathophysiology of depression. Interestingly, these pathways may be linked given that …

Purpose The purpose of the current study was to investigate the mediatory role between
vigorous physical activity, body mass index (BMI), and cardiorespiratory fitness on symptoms …

Major depressive disorder (MDD) is a common, chronic, recurrent mental illness that affects
millions of individuals worldwide. To date, the monoaminergic systems (serotonin …

The measurement of brain metabolites with magnetic resonance spectroscopy (MRS)
provides a unique perspective on the brain bases of neuropsychiatric disorders. As a context …

Background Sarcopenia, obesity, and sarcopenic obesity are various features of the ageing
process that can cause important health issues. The present study was undertaken to …

Previous research has shown that type 2 diabetes mellitus (T2DM) is associated with an
increased risk of cognitive impairment. Patients with impaired cognition often show …